https://www.fda.gov/regulatory-information/search-fda-guidance-documents/enforcement-policy-non-invasive-remote-monitoring-devices-used-support-patient-monitoring-during?utm_campaign=2020-03-20%20Remote%20Monitoring%20Devices%20Used%20to%20Support%20Patient%20Monitoring%20During%20COVID-19&utm_medium=email&utm_source=Eloqua

FDA Issues New Policy on Remote Monitoring Devices Used to Support Patient Monitoring During COVID-19

Today, the U.S. Food and Drug Administration (FDA) issued an immediately in effect guidance that allows manufacturers of certain FDA-cleared non-invasive, vital-sign-measuring devices to expand their use so that health care providers can use them to monitor patients remotely. The devices include those that measure body temperature, respiratory rate, heart rate and blood pressure. This policy reflects FDA’s commitment to ease burdens on health care providers and facilities as they face COVID-19.

Read the Guidance

Questions? If you have questions about this guidance, contact the Division of Industry and Consumer Education.